Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Amrubicin
Small Cell Lung Carcinoma
AbbVieP3BB (71)
Antihemophilic Factor,Human,Method M,Monoclonal
Hemophilia A
Dhaka Medical CollegeP3BB (71)
Asparaginase
B-Cell Acute Lymphoblastic Leukemia
University of WashingtonP3BB (71)
Autologous Cd34+ Cells Isolated From Mobilised Peripheral Blood By Positive Selection, Modified By Crispr/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/Crispr-Associated Protein 9) Mediated Gene Editing Consisting Of A Guide Rna (Grna) Introduced Transiently As Ribonucleoprotein (Rnp) Complex, Targeting The Erythroid Lineage-Specific Enhancer Region Of Bcl11A (B-Cell Lymphoma/Leukemia 11A). The Site-Specific Cleavage By Cas9 Forms A Double Strand Break (Dsb), Which Is Subsequently Repaired By Nonhomologous End-Joining (Nhej), Leading To The Transcriptional Repression Of Bcl11A, A Repressor Of ?-Globin Gene Transcription
Disease Of Genetic Or Genomic Mechanism
Vertex Pharmaceuticals IncorporatedP3BB (71)
Autologous Cd34+ Cells Isolated From Mobilised Peripheral Blood By Positive Selection, Modified By Crispr/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/Crispr-Associated Protein 9) Mediated Gene Editing Consisting Of A Guide Rna (Grna) Introduced Transiently As Ribonucleoprotein (Rnp) Complex, Targeting The Erythroid Lineage-Specific Enhancer Region Of Bcl11A (B-Cell Lymphoma/Leukemia 11A). The Site-Specific Cleavage By Cas9 Forms A Double Strand Break (Dsb), Which Is Subsequently Repaired By Nonhomologous End-Joining (Nhej), Leading To The Transcriptional Repression Of Bcl11A, A Repressor Of ?-Globin Gene Transcription
Thalassemia
Vertex Pharmaceuticals IncorporatedP3BB (71)
Benzeneethanamine, N-Ethyl-?-Methyl-4-(Trifluoromethyl)-, Hydrochloride, (±)-
Lennox-Gastaut Syndrome
University of ChicagoP3BB (71)
Bezisterim
Alzheimer Disease
Neurological Associates of West Los AngelesP3BB (71)
Bortezomib
Lymphoblastic Lymphoma
M.D. Anderson Cancer CenterP3BB (71)
Brentuximab Vedotin
Anaplastic Large Cell Lymphoma
Seagen Inc.P3BB (71)
Camizestrant
Breast Cancer
AstraZenecaP3BB (71)
Camustine
Glioblastoma
Leland MethenyP3BB (71)
Camustine
Lymphoma
VIVUS LLCP3BB (71)
Carboplatin
Adenosquamous Lung Carcinoma
NRG OncologyP3BB (71)
Carboplatin
B-Cell Non-Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd.P3BB (71)
Carboplatin
Bronchial Neoplasm
Nanfang Hospital, Southern Medical UniversityP3BB (71)
Carboplatin
Bronchogenic Carcinoma
Nanfang Hospital, Southern Medical UniversityP3BB (71)
Carboplatin
Chemotherapy-Induced Toxicity
Endeavor HealthP3BB (71)
Carboplatin
Fallopian Tube Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesP3BB (71)
Carboplatin
Female Reproductive System Neoplasm
Wenjun ChengP3BB (71)
Carboplatin
Invasive Breast Carcinoma
Baylor Breast Care CenterP3BB (71)
Carboplatin
Metastatic Prostate Carcinoma
Case Comprehensive Cancer CenterP3BB (71)
Carboplatin
Ovarian Disorder
Fujian Cancer HospitalP3BB (71)
Carboplatin
Respiratory Tract Neoplasm
Fundación GECPP3BB (71)
Chlorambucil
MALT Lymphoma
International Extranodal Lymphoma Study Group (IELSG)P3BB (71)
Cis-Diamminedichloroplatinum Ii
Non-Small Cell Squamous Lung Carcinoma
Gruppo Oncologico Italiano di Ricerca ClinicaP3BB (71)
Showing 2326 to 2350 of 42,286 assets
PreviousPage 94 of 1692Next